1. Home
  2. NGVT vs ARQT Comparison

NGVT vs ARQT Comparison

Compare NGVT & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NGVT
  • ARQT
  • Stock Information
  • Founded
  • NGVT 1964
  • ARQT 2016
  • Country
  • NGVT United States
  • ARQT United States
  • Employees
  • NGVT N/A
  • ARQT N/A
  • Industry
  • NGVT Major Chemicals
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NGVT Industrials
  • ARQT Health Care
  • Exchange
  • NGVT Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • NGVT 2.1B
  • ARQT 1.9B
  • IPO Year
  • NGVT N/A
  • ARQT 2020
  • Fundamental
  • Price
  • NGVT $58.13
  • ARQT $17.29
  • Analyst Decision
  • NGVT Buy
  • ARQT Strong Buy
  • Analyst Count
  • NGVT 2
  • ARQT 7
  • Target Price
  • NGVT $58.00
  • ARQT $19.00
  • AVG Volume (30 Days)
  • NGVT 266.6K
  • ARQT 1.5M
  • Earning Date
  • NGVT 10-28-2025
  • ARQT 11-05-2025
  • Dividend Yield
  • NGVT N/A
  • ARQT N/A
  • EPS Growth
  • NGVT N/A
  • ARQT N/A
  • EPS
  • NGVT N/A
  • ARQT N/A
  • Revenue
  • NGVT $1,324,800,000.00
  • ARQT $263,464,999.00
  • Revenue This Year
  • NGVT N/A
  • ARQT $72.46
  • Revenue Next Year
  • NGVT $5.18
  • ARQT $32.00
  • P/E Ratio
  • NGVT N/A
  • ARQT N/A
  • Revenue Growth
  • NGVT N/A
  • ARQT 99.50
  • 52 Week Low
  • NGVT $28.49
  • ARQT $8.03
  • 52 Week High
  • NGVT $60.77
  • ARQT $18.15
  • Technical
  • Relative Strength Index (RSI)
  • NGVT 59.21
  • ARQT 61.58
  • Support Level
  • NGVT $56.99
  • ARQT $15.13
  • Resistance Level
  • NGVT $60.77
  • ARQT $18.15
  • Average True Range (ATR)
  • NGVT 1.48
  • ARQT 0.66
  • MACD
  • NGVT -0.39
  • ARQT 0.14
  • Stochastic Oscillator
  • NGVT 42.73
  • ARQT 71.80

About NGVT Ingevity Corporation

Ingevity Corp is a chemical manufacturer based in the United States. It conducts its operations through three segments, namely Performance Chemicals, Advanced Polymer Technologies, and Performance Materials. The bulk of its revenue is generated by the Performance Chemicals segment which deals with the manufacture and sale of specialty chemicals that find their use in a range of processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment, on the other hand, focuses on automotive carbon products used in automobiles. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers. The Company generates the majority of its revenue from North America.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: